Canada Pension Plan Investment Board Lyell Immunopharma, Inc. Transaction History
Canada Pension Plan Investment Board
- $95.7 Billion
- Q1 2025
A detailed history of Canada Pension Plan Investment Board transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 588,235 shares of LYEL stock, worth $247,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
588,235
Previous 588,235
-0.0%
Holding current value
$247,058
Previous $376,000
15.69%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$8.47 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$6.72 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.34 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.34 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.67 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $104M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...